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Abstract: Deep brain stimulation (DBS) has emerged as a novel therapy for the treatment of several
movement and neuropsychiatric disorders, and may also be suitable for the treatment of Tourette
syndrome (TS). The main DBS targets used to date in patients with TS are located within the
basal ganglia-thalamo-cortical circuit involved in the pathophysiology of this syndrome. They
include the ventralis oralis/centromedian-parafascicular (Vo/CM-Pf) nucleus of the thalamus and
the nucleus accumbens. Current DBS treatments deliver continuous electrical stimulation and are not
designed to adapt to the patient’s symptoms, thereby contributing to unwanted side effects. Moreover,
continuous DBS can lead to rapid battery depletion, which necessitates frequent battery replacement
surgeries. Adaptive deep brain stimulation (aDBS), which is controlled based on neurophysiological
biomarkers, is considered one of the most promising approaches to optimize clinical benefits and
to limit the side effects of DBS. aDBS consists of a closed-loop system designed to measure and
analyse a control variable reflecting the patient’s clinical condition and to modify on-line stimulation
settings to improve treatment efficacy. Local field potentials (LFPs), which are sums of pre- and
post-synaptic activity arising from large neuronal populations, directly recorded from electrodes
implanted for DBS can theoretically represent a reliable correlate of clinical status in patients with TS.
The well-established LFP-clinical correlations in patients with Parkinson’s disease reported in the last
few years provide the rationale for developing and implementing new aDBS devices whose efficacies
are under evaluation in humans. Only a few studies have investigated LFP activity recorded from
DBS target structures and the relationship of this activity to clinical symptoms in TS. Here, we review
the available literature supporting the feasibility of an LFP-based aDBS approach in patients with TS.
In addition, to increase such knowledge, we report explorative findings regarding LFP data recently
acquired and analysed in patients with TS after DBS electrode implantation at rest, during voluntary
and involuntary movements (tics), and during ongoing DBS. Data available up to now suggest that
patients with TS have oscillatory patterns specifically associated with the part of the brain they are
recorded from, and thereby with clinical manifestations. The Vo/CM-Pf nucleus of the thalamus is
involved in movement execution and the pathophysiology of TS. Moreover, the oscillatory patterns
in TS are specifically modulated by DBS treatment, as reflected by improvements in TS symptoms.
These findings suggest that LFPs recorded from DBS targets may be used to control new aDBS devices
capable of adaptive stimulation responsive to the symptoms of TS.
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1. Introduction
Tourette syndrome (TS) is a complex condition characterized by tics and is often accompanied
by psychiatric comorbidities. The treatment of TS is thus still challenging, especially in a subset of
drug-refractory and severely affected patients [1]. In the last 15 years, deep brain stimulation (DBS)
has emerged as a promising therapeutic intervention for TS, with more than 100 patients with TS
implanted worldwide [2].
DBS consists of the placement of deep brain electrodes in a target structure. These electrodes are
connected to an implanted pulse generator that delivers high-frequency (>100 Hz) electrical stimulation.
While the optimal target has already been determined in other pathologies, such as dystonia, essential
tremor, and Parkinson’s disease [3], several different targets have been reported for TS [2,4]. The
stimulation of these targets has led to both success and failure. The medial part of the thalamus [2]
(centro-median nucleus (CM), ventralis oralis nucleus (Vo), and parafascicular nucleus (Pf)), the globus
pallidus internus [5] (GPi, anterior and posteroventrolateral parts), the internal capsule, the nucleus
accumbens (NA), and the fields of Forel (H1) [6] have all been explored as DBS targets in TS. Findings
from the different studies reported in the literature suggest that, apart from network considerations, the
choice of target should be driven by the potential to reduce the different comorbidities associated with
TS in addition to the aim of reducing tics [7]. In addition to differences in target selection, differences
in the age of inclusion contribute to the heterogeneity of the available results [8]. In the long term
(7–9 years), thalamic DBS led to a 50% reduction in tics, suggesting an overall efficacy in patients with
severe refractory TS [9]. This type of stimulation is thus thought to have the potential to improve social
functioning [10]. However, DBS is often associated with post-surgery complications [2] that lead to
imbalances between side effects and therapeutic effects, and often leads to the switching off of the
stimulator or to new surgeries for the placement of additional electrodes in different brain areas [11].
TS is a movement and neuropsychiatric disorder characterized by fluctuation, while DBS is
delivered continuously, in a constant manner, without any adaptation of the stimulation paradigm to
the tic dynamic. This is the same line of reasoning applied to DBS for the treatment of Parkinson’s
disease. This has led to the proposal of novel closed-loop, adaptive DBS (aDBS) approaches to change
stimulation parameters based on the patient’s clinical state [12–14]. In Parkinson’s disease, the aDBS
approach tested in humans is based on a strategy of adapting stimulation parameters (amplitude)
based on changes in the patterns of local neuronal activity (i.e., local field potentials, LFPs) recorded
through the implanted DBS electrode while DBS is turned on. The large body of literature showing that
LFP patterns are representative of the clinical state in Parkinson’s disease has guided the technological
development of aDBS.
The only alternative to classical continuous DBS for the treatment of TS proposed up to now is
“intermittent” stimulation [15,16]. In the proposed “scheduled” paradigm, DBS is delivered following
an a priori determined schedule that decreases the time during which DBS is switched on. In fact, an
average of 2.3 h/day of stimulation has been shown to lead to significant improvement in the Yale
Global Tic Severity Scale after 2 years [15].
Considering that LFPs have also been recorded and analysed from DBS electrodes in patients
with TS, and that the LFP patterns have specific characteristics during tics, it can be hypothesized that
LFP-based aDBS approaches may also be used for the treatment of refractory TS [17–21]. Here we
provide a review of the available literature supporting the feasibility of an LFP-based aDBS approach
for the treatment of TS. To further support this hypothesis, we also report explorative findings regarding
LFPs recently recorded in patients with TS after DBS electrode implantation. After a short explanation
of the concept of adaptive DBS guided by LFPs, we discuss the specific LFP signature in TS at rest,
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during voluntary and involuntary movements (tics), and during ongoing DBS in separate sections of
the manuscript. The discussion section summarizes the results reported in the literature and those of
the additional experiments reported here, and considers the feasibility of aDBS in patients with TS.
2. The LFP-Based aDBS Concept
Adaptive DBS is based on a model whereby the implanted aDBS device measures and analyses
a variable (called the “control variable”) that correlates with the patient’s clinical state. The device
then changes the DBS parameters according to these data to provide optimal moment-by-moment
stimulation to control the patient’s symptoms. The new stimulation paradigm, which would change
the patient’s state, would in turn induce a change in the control variable, which is measured and
analysed again, thus closing the loop. In aDBS, the choice of the control variable should take into
account some important technological, practical, and clinical requirements. More specifically, the
control variable should be measured without the need for additional implants and must reflect the
patient’s state. In addition, the processing and computational costs of the analysis should be kept low
to ensure low power consumption. Finally, the implantation of an aDBS system should not change
normal clinical practice, and it should not impact the patient’s acceptance [22].
Compound pre-synaptic and post-synaptic activities of the local neuronal populations recorded
using DBS electrodes, named LFPs, have been chosen as the most promising control variable for
aDBS, at least in Parkinson’s disease [22]. LFPs recorded from one (monopolar recording) or two
(bipolar recording) contacts on the implanted DBS electrode do not require additional implants or any
specific changes to neurosurgical procedures. Moreover, as the aDBS technology is included in the
same implantable device (the only change is inside the neurostimulator), the level of acceptance of
LFP-based aDBS is the same as that of DBS. The bulk of evidence collected in almost 20 years of research
on LFPs indicates that they are characterised by oscillations through which they encode information
within the cortico-basal ganglia-thalamo-cortical loop. LFP oscillations occur over a wide frequency
spectrum and include the very low-frequency band (range: 2–7 Hz), alpha/low beta band (range:
8–20 Hz), high beta band (range: 20–35 Hz), gamma band (range: 60–80 Hz), and very high-frequency
band (range: 250–350 Hz). Each oscillation band is specifically modulated by changes in the patient’s
clinical state and movement execution, and by cognitive and behavioural stimuli [22–25].
The large majority of LFP studies have been conducted in the short time window between
stereotactic neurosurgery for electrode implantation and the implantation of the subcutaneous pulse
generator, known as the “acute” phase. However, since it is a transient and continuously evolving
condition, this acute phase cannot be representative of the “chronic” condition during which DBS is
delivered. Therefore, other experiments have been conducted in patients in need of battery replacement
surgery after up to 7 years of DBS [26]. These experiments have been crucial in establishing that LFPs
are consistently recordable over time, thus confirming the feasibility of LFP-based aDBS.
LFPs have been recorded not only in patients with Parkinson’s disease, but also in those with other
movement and neuropsychiatric disorders treated with DBS, including Tourette syndrome. Different
LFP patterns characterize different pathologies and conditions, suggesting that an LFP-based adaptive
strategy is feasible not only in Parkinson’s disease, but also in other conditions.
2.1. Experiment 1: LFPs in Tourette Syndrome at Rest
LFP recordings obtained at rest from the thalamus in patients with TS during tic-free epochs are
characterized by activity predominantly at low-frequencies (2–7 Hz) and in the alpha band (8–13 Hz),
but not in the beta band (20–35 Hz) [20]. Increased low-frequency intra-thalamic coherence has been
reported to not be time-locked with motor tics [18].
This LFP pattern is consistent with the hypothesis that increased bursting of thalamic cells in
the range of the low-frequency band generates so-called thalamo-cortical dysrhythmia, which in
turn results in increased coherence between low-frequency and high-frequency rhythms [27]. The
low-frequency pattern observed in TS also resembles the increase within the low-frequency band
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across the basal ganglia-thalamo-cortical loop, which characterizes hyperkinetic disorders, such as
dystonia or parkinsonian dyskinesias [28,29].
Speculation that unbalanced low-frequency activity contributes to the hyperkinetic signature
of TS is further supported by LFP recordings in the GPi in patients with Tourette syndrome.
These recordings have revealed a consistent increase in low-frequency activity, together with
low-frequency/high-frequency synchronization (200–400 Hz) [17]. We therefore conducted additional
experiments to further confirm the reported LFP patterns of DBS targets in patients with TS.
2.1.1. Methods and Participants
To further confirm the above-mentioned results, we studied 7 patients with severe TS (5 men
and 2 women, age range: 24–47 years, Table 1) refractory to standard drug treatment, satisfying the
DSM-IV-TR (American Psychiatric Association, APA 2000) and World Health Organization criteria for
TS (WHO 1992). The patients underwent DBS surgery at the Functional Neurosurgery Unit at IRCCS
Galeazzi hospital. The patients were bilaterally implanted with macroelectrodes for DBS (model 3389,
Medtronic; Minneapolis, MN, USA) either in the ventralis oralis/centromedian-parafascicular
(Vo/CM-Pf) nucleus of the thalamus or the NA (see Table 1 for clinical and DBS details). The surgical
procedure is fully described elsewhere [20,30]. The study was approved by the local Ethical Committee
of the IRCCS Galeazzi hospital and conformed to the declaration of Helsinki. All patients provided
written informed consent. We recorded LFPs during the “acute” phase 4–5 days after surgery for
electrode placement. LFP recordings at rest (patients seated on an armchair) were captured bipolarly
from the available contact pairs (0–1, 1–2, and 2–3), first from the right electrode and then from
the left electrode. Signals were acquired using a Galileo BE Light electroencephalography (EEG)
amplification system (EBNeuro Spa; Florence, Italy) with a 2–500 Hz band pass filter, a 1024 Hz
sampling frequency, and 12-bit quantization over a 5 V range. Data were analysed off-line using Matlab
software (version 7.10, The MathWorks; Natick, MA, USA). After preliminary 125 Hz resampling,
oscillatory activity was quantified in the frequency domain by analysing the power spectral density
(PSD) using Welch’s averaged modified periodogram with a resolution of 1 Hz [31].
Table 1. Demographic and deep brain stimulation (DBS) details for the patients recorded during the
acute phase.
Patient
ID Gender
Age
(Years)
Severe Psychiatric
Comorbidity
DBS
Target
Preoperative
Assessment
12 Months
Assessment
YBOCS YGTSS YBOCS YGTSS
1 m 39 Vo/CM-Pf 12 75 10 40
2 m 42 Vo/CM-Pf 12 79 11 70
3 f 47 Vo/CM-Pf 17 45 20 29
4 m 40 Vo/CM-Pf 3 65 5 35
5 m 27 Vo/CM-Pf 17 28 0 14
6 m 24 x NA 23 79 11 48
7 f 29 x NA 37 70 30 70
m = male. f = female. DBS = deep brain stimulation. YBOCS = Yale-Brown Obsessive-Compulsive Scale;
YGTSS = Yale Global Tic Severity Scale.Vo/CM-Pf = Ventralis Oralis Centro Median Parafascicular thalamic
nucleus. NA = Nucleus Accumbens.
2.1.2. Results
LFPs recorded from the Vo/CM-Pf nuclei (n = 8) revealed two main oscillatory activity patterns:
one in the low-frequency band (2–7 Hz) and one in the alpha band (8–13 Hz). No spectral peak in
the beta band was detected in any nucleus. The low-frequency band intensity in the LFP recordings
obtained from contacts 0–1 was higher than that obtained from the other contacts (Figure 1A). It was
possible to isolate only one main oscillation pattern in the LFPs recorded from the NA (n = 4). This
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activity in the low-frequency band was higher in recordings from the most caudal contacts (0–1) than
in those from the other contacts (Figure 1B).
1 
 
Figure1 
 
Figure 1. LFP power spectrum at rest obtained from the Vo/CM-Pf and NA nuclei. (A) Average power
spectrum across all Vo/CM-Pf nuclei (n = 8) obtained from LFPs captured from contacts 0–1 (black
solid line), 12 (dashed black line), and 23 (dashed grey line). The x-axis represents frequency (Hz) and
the y-axis represents the normalized power spectral density (PSD, arbitrary units). (B) Average power
spectrum across all NA nuclei (n = 4) obtained from LFPs captured from contacts 0–1, 1–2, and 2–3.
The plot is organised as it is in panel A.
2.2. Experiment 2: LFPs in Tourette Syndrome during Voluntary Movements
LFP recordings from the thalamus [18] and the GPi [17] during voluntary movement have been
reported in a limited number of patients. In contrast to tics, voluntary movements are characterized by
cortical involvement represented by a pre-motor potential arising before movement execution [18],
and by increased alpha activity in the GPi [17].
2.2.1. Methods and Participants
To build on the previously reported observations, we recorded bilateral LFPs during both
self-paced and externally-cued movements of the upper limbs in the same 7 patients with TS described
in the previous section (Table 1). The patients were instructed to lift their upper limb every 10 s as
quickly as possible 15 times (right limb first, LFPs recorded bilaterally). To monitor the movements,
electromyography (EMG) signals were recorded from the anterior deltoid muscle using a pair of
Ag/AgCl electrodes. After a rest period to avoid fatigue, the patients were instructed to lift their
upper limb after an external cue (right limb first). To determine the time course of single oscillatory
bands during the movements, we used the squared module of the Hilbert transform applied to
LFPs band-passed in each band of interest (low-frequency (2–7 Hz) alpha (8–13 Hz), and high beta
(20–35 Hz)), as previously described [32].
2.2.2. Results
We excluded some LFP traces from the analysis due to movement artefacts that reduced the
quality of the signals. Based on the results reported for the GPi, the most consistent power modulations
during voluntary movements occur in the low-frequency and alpha bands. Low-frequency power
increased during the movement phase for both externally-cued and self-paced movements. The
low-frequency power increase was more prominent for externally-cued movements than for self-paced
movements, and began before movement onset (pre-movement phase) only for externally-cued
movements. Similarly, the alpha power modulation had an increase in the pre-movement phase only
for the externally-cued movements (Figure 2A,B). Table 2 details the average percentage changes and
the timing of the observed modulations.
Brain Sci. 2018, 8, 4 6 of 15
1 
 
Figure 2 
Figure 2. Vo/CM-Pf LFP power modulation during voluntary movements. (A) Grand average (n = 7)
of the low-frequency (left plot), alpha (central plot), and high beta (right plot) power modulations
during self-paced voluntary movements (solid black line) and externally-cued movements (dashed
black line). Power modulations are expressed as percentage changes from the baseline phase and were
estimated starting from 1.5 s before the movement onset until 2 s after the movement onset. The four
movement-related phases were baseline (b), pre-movement (p), movement (m), and recovery (r). x-axis:
time (s); y-axis: Hilbert-power modulations (Percentage). (B) The histograms represent the mean power
modulation for low-frequency (left plot), alpha (central plot), and high beta (right plot) bands in the
four movement phases (baseline, pre-movement, movement, and recovery) for self-paced movements
(black bars) and externally-cued movements (grey bars). Error bars represent the standard error.
Table 2. Summary of average LFP modulations observed in the Vo/CM-Pf thalamic nucleus during
voluntary and involuntary movements in the low-frequency (2–7 Hz) and alpha (8–13 Hz) bands in
patients with TS.
Movement Type
Low-Frequency (2–7 Hz) Alpha (8–13 Hz)
Onset (ms) Duration (ms) % Change Onset (ms) Duration (ms) % Change
Voluntary
movement
Pre-movement
[−500 0] ms −250 250 +40% −250 250 +20%
Movement
[0 1000] ms 0 800 +60% 0 500 +60%
Recovery
[1000 2000] ms 800 1200 +20% 500 1500 +20%
Involuntary
movement
Pre-tic
[−500 0] ms - - - −250 250 −20%
Tic
[0 1000] ms 0 1000 150% 0 1000 150%
Recovery
[1000 2000] ms 1000 2000 100% - - -
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2.3. Experiment 3: LFPs during Involuntary Movements
Studying LFP activity during tics is one of the most important steps in establishing whether aDBS
is feasible in patients with Tourette syndrome. However, the immediate post-surgical lesion effect
likely decreases the occurrence of tics in patients with TS undergoing DBS. This limits the possibility
of obtaining significant data using acute LFP recordings. In addition, the presence of the sensory
phenomenon of feeling an “urge to move” (premonitory urge), which is relieved by tic expression, has
been documented as a distinct feature of TS [33]. This suggests the need to study the neurophysiological
correlates of such phenomena to better understand the phenomenology of TS tics. However,
neuroimaging studies have reported that premonitory urge is mainly associated with activation of the
neocortical and paralimbic areas, and some activation in the putamen, caudate, and claustrum [34].
There are no LFP studies specifically reporting observations regarding premonitory urge.
Increased gamma (35–200 Hz) and high-frequency oscillations (200–400 Hz) in the GPi have been
reported during tics. These changes are associated with synchronization of the high-frequency activity
and the beta band [17], which is consistent with cortical beta desynchronization before tics [19]. In
the thalamus, low-frequency (below 10 Hz) and high-frequency (30–100 Hz) activity is higher during
tics [19]. This is associated with increased thalamocortical coherence observed immediately before tic
onset [18].
Shute and colleagues [19] have used the Medtronic Activa PC implanted pulse generator (IPG)
with stimulation disabled during data collection. Use of this implanted device allowed the authors to
overcome the post-surgical limitations of acute recordings. Interestingly, the authors reported that,
using the increased LF activity, tics had a highly detectable thalamocortical signature with an average
sensitivity of 88.6% and an average precision of 96.3% over a 6-month period. However, this study
used cortical electrodes to increase the precision of tic detection, which required the inclusion of an
adjunctive device to be implanted. This represents a limitation of the aDBS approach.
2.3.1. Results
In our sample of 7 patients with TS undergoing DBS, only one patient with the implant in the
Vo/CM-Pf showed tics during recording in the acute phase (patient no. 3 in Table 1). The patient had
severe motor tics in both the upper and lower limbs. In this patient, LFP recordings revealed two main
oscillatory activity patterns that changed during tics: one in the low-frequency band and the other in
the alpha band (Figure 3A). Low-frequency power increased from baseline during both the movement
phase and the recovery phase for both the upper and lower limb tics. Alpha power also increased
from baseline during the movement and recovery phases for the lower limb tics, and only during the
movement phase for the upper limb tics (Figure 3B,C). The alpha band also had desynchronization
in the pre-movement phase, particularly during the upper-limb tics. This desynchronization, even
though scarcer and anticipated in time, was also observable during the lower-limb tics. Table 2 details
the average percentage changes and timing of the observed modulations.
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Figure 3. Vo/CM-Pf LFP oscillations during involuntary movements in one patient. (A) Power
spectrum of LFPs captured from the Vo/CM-Pf nucleus using contacts 0–1 (black solid line), 12 (dashed
black line), and 23 (dashed grey line) during motor tics. The x-axis represents frequency (Hz) and
the y-axis represents the normalized power spectral density (PSD, arbitrary unit). (B) LFP power
modulations for the low-frequency, alpha, and high beta bands recorded during upper limb tics from
the electrode contact pairs 0–1 and 1–2, averaged across all observed tics. Power modulations are
expressed as percentage changes from the baseline phase and were estimated starting 1.5 s before
the movement onset until 2 s after the movement onset. The four movement-related phases were
baseline (b), pre-movement (p), movement (m), and recovery (r). X-axis: time (s); y-axis: Hilbert-power
modulations (%). (C) LFP power modulations for the low-frequency, alpha, and high beta bands
recorded during lower limb tics from electrode contact pairs 0–1 and 1–2, averaged across all observed
tics. The plots are organised as they are in panel B.
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2.4. Experiment 4: Chronic LFP Recordings during DBS
There are no reports in the literature of ipsilateral LFP recordings from the same electrode during
DBS in patients with TS, likely due to certain technical challenges needing to be addressed in order to
guarantee accurate recordings [18,35]. We have previously developed a device able to record LFPs
from the electrode delivering DBS. We have used this device to obtain LFP recordings from patients
with Parkinson’s disease during stimulation from the same electrode. This device is called FilterDBS
(Newronika srl, Milan, Italy) [35].
2.4.1. Methods and Participants
Using FilterDBS, we recorded LFPs at rest (baseline, 3 min), during ongoing DBS (DBS ON, 6 min),
and after the DBS was turned off (post-DBS, 3 min). We performed the recordings in 8 patients with
severe TS (6 men and 2 women, age range: 24–48 years) treated with DBS for 1–7 years (Table 3) who
were in need of battery replacement. Using the above strategy, we avoided the lesional effects typical
of acute recordings and demonstrated that LFPs are consistently recordable years after DBS. The study
was approved by the local Ethical Committee of the IRCCS Galeazzi hospital and conformed to the
declaration of Helsinki. All patients provided written informed consent.
Table 3. Demographic and deep brain stimulation (DBS) details of the patients recorded in the
chronic phase.
Patient Gender Age(Year)
Preoperative
Assessment
12 Months
Assessment DBS Target
Chronic
Stimulation
for (Years)
Recording
Contacts
Impedance
of the
Recording
Contacts
(kΩ)
YBOCS YGTSS YBOCS YGTSS
1 m 31 32 92 18 40 Vo/CM-Pf 7 Right 46 4.5
Left 02 5.1
2 m 35 21 89 14 38 Vo/CM-Pf 5 Right 57 3
Left 02 6.2
3 m 48 20 78 14 30 Vo/CM-Pf 2 Left 12 7.6
4 f 25 25 78 19 40 Vo/CM-Pf N/A Right 46 4.7
Left 02 3.7
5 m 38 30 42 26 26 Vo/CM-Pf N/A Right 46 7
6 m 24 0 28 2 25 Vo/CM-Pf 1 Right 47 0
Left 03 4.9
7 f 39 5 56 11 31 Vo/CM-Pf 4 Right 46 5
Left 02 7.3
Right 46 3.8
8 m 29 38 69 21 20 NA 3 Left 02 2.2
m = male. f = female. DBS = deep brain stimulation. YBOCS = Yale-Brown Obsessive-Compulsive Scale;
YGTSS = Yale Global Tic Severity Scale.Vo/CM-Pf = Ventralis Oralis Centro Median Parafascicular thalamic
nucleus. NA = Nucleus Accumbens.N/A = Not Available.
LFP recordings took place in the surgery room while the lead extensions were exposed before
connection to the new implanted stimulator. Therefore, the experimental setting limited our recordings
to those obtained at rest (no movement-related or tic-related LFPs were recorded) with and without
DBS turned on.
2.4.2. Results
We observed that DBS modulates LFP oscillatory activity by specifically increasing low-frequency
power from baseline. The other power frequencies remained unchanged. After DBS was turned off, LF
power decreased and returned to the baseline LF power value (Figure 4A,C). In one patient (patient
no. 5, Table 3), we also observed a decrease in the alpha band when DBS was turned on. The alpha
band value returned to baseline after DBS was turned off (Figure 4B,D).
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Figure 4. The LFP power spectrum obtained from the Vo/CM-Pf during ongoing DBS. (A) Mean power
spectrum across all Vo/CM-Pf nuclei (n = 6) for LFPs at rest (black solid line), during ongoing DBS
(grey solid line), and after DBS (black dashed line). The x-axis represents frequency (Hz) and the y-axis
represents the normalized power spectral density (PSD, arbitrary unit). (B) LFP power spectrum from
a single patient (case 5 in Table 3) during ongoing DBS. The plot is organized as in panel A. (C) The
histograms represent the mean LFP spectral power (n = 6) for low-frequency, alpha, low beta, and
high beta bands during the three experimental conditions: baseline (dark grey), DBS (middle grey),
and post-DBS (light grey). Error bars represent standard errors. (D) The histograms represent the LFP
spectral power in case 5. The histograms are organised as they are in panel C.
We hypothesize that DBS saturates low-frequency oscillations, which in turn are no longer
available for the thalamo-cortical communication characterizing tics. This effect, which occurs
ipsilateral to the site of stimulation, may work in synergy with the suppression of the alpha rhythm
observed in one patient, which has consistently been observed on the side contralateral to the
stimulation in other groups [18].
3. Discussion
The results reported in the literature, together with the original results reported here, suggest that
LFP-based aDBS may be feasible in patients with TS. These results, however, have been obtained mainly
in the thalamus, which is one of the first targets explored for DBS in TS. This limits the possibility of
designing LFP-based aDBS algorithms dedicated to other targets. This is an area of research requiring
further experiments.
In support of the feasibility of LFP-based aDBS, we know that thalamic LFPs show consistent
modulations in patients with TS, particularly in the LF (2–7 Hz) and alpha (8–13 Hz) bands during
tics, during voluntary movements, and during DBS. In addition, thalamic low-frequency modulation
has been shown to be effective as a readout for recognizing tics [19]. Involuntary movements are
characterized by a decrease in alpha band activity (−20%) for 250 ms, which is followed by a large
increase (+150%) in both LF and alpha band activity for at least 1 s (Table 2). Conversely, voluntary
movements are characterised by increased LF band activity (+40%) and a small increase (maximum of
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20%) in alpha band activity for 250 ms, followed by an increase (+60%) in both LF and alpha band
activity for at least 500 ms (Table 2). We provided evidence that LFPs can still be recorded after years
of stimulation and when DBS is turned on without the need for additional implants. This supports the
feasibility of chronic LFP-based aDBS in patients with TS. Finally, in contrast to the classical feedback
approach used in Parkinson’s disease [13,14,22], the findings obtained in patients with TS suggest that
a feed-forward strategy may be preferable [16].
If the observations made in our limited sample are confirmed in larger studies, we would speculate
that, in patients implanted with thalamic DBS devices, monitoring of thalamic alpha and LF power
changes in windows of 250 ms should be sufficient to detect significant changes in the oscillatory
pattern. We would then be able to use these changes to identify tics and to change specific DBS
parameters. As an example of the potential applicability of an LFP-based aDBS approach, Figure 5
shows an adaptive feed-forward strategy to change DBS parameters when tic onset is potentially
detected based on the available LFP characteristics during involuntary movements. Based on this
hypothesis, DBS may be delivered continuously with the optimized parameters set for each patient
(usually 130 Hz with a 2–5 V amplitude range and a 60–120 µs pulse-width range). LFPs are recorded
during DBS. The adaptive system may extract the LF and alpha bands by applying a band-pass filter
(one for LF at 2–7 Hz and one for alpha at 8–13 Hz) followed by a 100 ms moving average filter. This
would allow us to observe LF and alpha changes over 100 ms with a 100 ms delay. These changes can
thus be detected in the time scale required for the detection of fast movement-related dynamics.
When a decrease in the alpha power of at least 20% lasting for at least 250 ms is detected, the
system verifies whether it is followed by a 150% increase in both the alpha and LF signals. If this is the
case, the DBS parameters are changed to decrease the LF signal and suppress the alpha changes. We
hypothesize that a decrease in the pulse width to 10–30 µs and a decrease in the frequency around the
high beta band (30–35 Hz) would help stop involuntary movements and decrease the LF and alpha
band activities. When the LF band returns to a maximum of +50%, the DBS can be switched to the
classical optimized parameters.
However, the scheme presented above is only a theoretical speculation based on the literature
and the current findings regarding tic detection and DBS effects on LFPs recorded in the thalamus in
patients with Tourette syndrome. The above approach has several important limitations. First, the
neurophysiological observations underlying the adaptive model were obtained in a limited number of
patients and should be confirmed in larger studies before they are considered conclusive. In addition,
tic phenomenology should take into account the presence of the premonitory urge [33], which would
further enhance the ability of the feed-forward strategy to suppress tics. In fact, if the premonitory urge
is recognised in neurophysiological recordings, it may be used as a trigger for specific DBS patterns
aimed to suppress the urge, which would otherwise be satisfied by tic expression. This would, in
effect, prevent tic onset. This hypothesis is at present purely speculative and would require targeted
experiments to specifically study the LFP signature (if any) of the premonitory urge and the ability of
DBS to satisfy the urge.
Finally, this first exploratory model for aDBS is based on data obtained from the thalamus and
grounding on previous technology developed for aDBS in Parkinson’s Disease [36]. As such, it does
not take into account psychiatric comorbidities that are observed in a large number of patients with
TS [37], which have recently led to the characterization of obsessive-compulsive tic disorder, which is a
reflection of obsessive-compulsive disorder and TS comorbidity [38]. The patients analysed here were,
for the most part, implanted in the Vo/CM-Pf thalamic complex. However, as for Parkinson’s disease,
LFP studies for TS have first focused on motor symptoms and then on cognitive dysfunctions [22].
Therefore, to propose an advanced aDBS model, new experiments specifically designed to evaluate
LFPs in domains such as attention, memory, executive function, language, motor, and visuomotor
functions should be conducted, especially in patients implanted in target areas, such as the anterior
GPi [38].
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Figure 5. Hypothesized adaptive feed-forward strategy for fast changes in deep brain stimulation
(DBS) parameters to control tics. LF = low-frequencies band (2–7 Hz), ALPHA = alpha band (8–13 Hz).
4. Conclusions
In conclusion, the present review, which was enriched by original results, provides some
indications supporting the hypothesis that LFP-based aDBS, at least in the thalamus, is feasible
in TS. Further studies in patients are required to better understand the LFP signatures of psychiatric
comorbidities and non-tic disease manifestations. These studies should include other DBS targets that
are now considered very promising for the treatment of TS, such as the anterior GPi.
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